Hubei Honch Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is VINORELBINE TARTRATE, with a corresponding US DMF Number 26091.
Remarkably, this DMF maintains an Active status since its submission on December 30, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 02, 2015, and payment made on June 11, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II